申请人:SANKYO COMPANY LIMITED
公开号:EP0882728A1
公开(公告)日:1998-12-09
[Constitution]
A 1-methylcarbapenem compound represented by the following formula (I):
wherein R1 represents a hydrogen atom or a lower alkyl group; R2 represents a hydrogen atom or an ester residue; and A represents a substituted prolylaminopyrrolidin-1-ylcarbonyl, substituted aminoalkanoylaminopyrrolidin-1-ylcarbonyl, 1-hydroxy-2-(substituted aminoalkylpyrrolidin-1-ylcarbonyl)ethyl, 1-hydroxy-2-(substituted piperazin-1-ylcarbonyl)ethyl, 1-hydroxy-2-(substituted pyrrolidinylaminocarbonyl)ethyl or the like; or a pharmacologically acceptable salt thereof.
[Advantages]
1-Methylcarbapenem compounds of the present invention have excellent antibacterial activity and they are useful agents for the prevention or treatment of infectious diseases.
[组织结构]
由下式(I)代表的1-甲基碳青霉烯类化合物:
其中 R1 代表氢原子或低级烷基;R2 代表氢原子或酯残基;A代表取代的脯氨酰氨基吡咯烷-1-基羰基、取代的氨基烷酰基氨基吡咯烷-1-基羰基、1-羟基-2-(取代的氨基烷基吡咯烷-1-基羰基)乙基、1-羟基-2-(取代的哌嗪-1-基羰基)乙基、1-羟基-2-(取代的吡咯烷氨基羰基)乙基或类似物;或其药理上可接受的盐。
优势
本发明的 1-甲基碳青霉烯化合物具有优异的抗菌活性,是预防或治疗传染性疾病的有效药物。